Celsion Corporation
Celsion Corporation's Overview
Celsion Corporation, which now operates as Imunon, Inc. (NASDAQ: IMNN) following a name change and rebranding in September 2022, is a clinical-stage biotechnology company. It is focused on advancing a portfolio of innovative treatments that harness the body's immune system and other cutting-edge technologies to combat cancer and infectious diseases. Imunon's pipeline includes programs in immuno-oncology and DNA-based vaccines. The company's lead clinical program, GEN-1, is a DNA-based immunotherapy for advanced ovarian cancer. Imunon is also developing its proprietary PLACCINE platform technology for the development of nucleic acid-based vaccines for infectious diseases and cancer.
Where is Celsion Corporation's Headquarters?
HQ Function
Serves as the global headquarters for Imunon (formerly Celsion Corporation), housing corporate offices, research and development activities, and clinical operations management.
Notable Features:
Modern office and laboratory facilities equipped for biopharmaceutical research and development. Specific architectural details are not widely publicized.
Work Culture:
A dynamic and science-driven environment focused on innovation in oncology and immunotherapy. Emphasizes collaboration, scientific rigor, and a patient-focused approach. As a smaller biotech, it likely fosters a close-knit, agile, and entrepreneurial culture.
HQ Significance:
The headquarters is central to Imunon's strategic planning, R&D activities for its GEN-1 program and PLACCINE platform, and coordination of global clinical trials. Its New Jersey location provides access to a rich ecosystem of talent and industry partners.
Values Reflected in HQ: The headquarters likely reflects values such as innovation, precision in research, and a commitment to advancing cancer treatment. The choice of a location within a biotech hub signifies a focus on collaboration and access to cutting-edge resources.
Location:
Imunon (formerly Celsion Corporation) primarily operates from its headquarters in Lawrenceville, New Jersey. Its global presence is mainly characterized by the conduct of clinical trials in multiple countries for its therapeutic candidates and potential collaborations with international partners for research, development, and commercialization.
Street Address:
997 Lenox Drive, Suite 100
City:
Lawrenceville
State/Province:
NJ
Country:
USA
Celsion Corporation's Global Presence
Buying Intent Signals for Celsion Corporation
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of Celsion Corporation
As of April 2025, Celsion Corporation' leadership includes:
Investors of Celsion Corporation
Celsion Corporation has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
In the past 12 months (as of mid-2024), Imunon (formerly Celsion Corporation) saw a key leadership transition with Michael H. Tardugno stepping down as Chairman of the Board in May 2023. No new executive team members were hired during this period, following the appointment of Dr. Corinne Le Goff as CEO in November 2022.
Departures
Technology (Tech Stack) used by Celsion Corporation
Discover the tools Celsion Corporation uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Celsion Corporation Email Formats and Examples
Imunon, Inc. (formerly Celsion Corporation) likely uses common corporate email formats. Based on standard practices in the biopharmaceutical industry, patterns such as [first_initial][last] or [first].[last] followed by @imunon.com are probable.
[first_initial][last]@imunon.com
Format
clegoff@imunon.com
Example
85%
Success rate
News and media
GlobeNewswire via Imunon Website • March 28, 2024
Imunon Reports Full Year 2023 Financial Results and Provides Corporate Update
Imunon, Inc. announced its financial results for the full year ended December 31, 2023, and provided an update on its clinical programs, including progress on its GEN-1 immunotherapy and PLACCINE vaccine platform....more
GlobeNewswire via Imunon Website • April 16, 2024
Imunon to Present at the MedInvest Oncology Investor Conference
Imunon announced that its President and CEO, Dr. Corinne Le Goff, would present a company overview and update at the MedInvest Oncology Investor Conference in April 2024, highlighting advancements in its therapeutic pipeline....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Celsion Corporation, are just a search away.